Your search history is turned on.
Date: February 21, 2024 Jurisdictions: British Columbia
Microsoft Word - December 31 2023 basic disclosure statement V.1.docx OTC Markets Group Inc. OTC Pink Basic Disclosure Guidelines (v4.0 January 1, 2023) Page 16 of 17 9) Financial Statements A. The following financial statements were prepared in accordance with: IFRS X U.S. GAAP B. The following financial statement...
Microsoft Word - December 31 2023 basic disclosure statement V.1.docx OTC Markets Group Inc. OTC Pink Basic Disclosure Guidelines (v4.0 January 1, 2023) Page 4 of 17 Disclosure Statement Pursuant to the Pink Basic Disclosure Guidelines Pharmagreen Biotech Inc. 112 North Curry Street Carson City, Nevada 89703 _______________________________ ...
Date: January 9, 2024 Jurisdictions: British Columbia
Issuer Certification Principal Financial Officer: I, Terry Kwan certify that: 1. I have reviewed this Annual Disclosure Statement for Pharmagreen Biotech Inc; 2. Based on my knowledge, this disclosure statement does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances...
Issuer Certification Principal Executive Officer: I, Peter Wojcik certify that: 1. I have reviewed this Annual Disclosure Statement for Pharmagreen Biotech Inc; 2. Based on my knowledge, this disclosure statement does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstance...
OTC Markets Group Inc. OTC Pink Basic Disclosure Guidelines (v4.0 January 1, 2023) Page 4 of 17 Disclosure Statement Pursuant to the Pink Basic Disclosure Guidelines Pharmagreen Biotech Inc. 112 North Curry Street Carson City, Nevada 89703 _______________________________ (702)-803-9404 www.pharmagreen.ca infor@pharmagree...
Date: August 22, 2023 Jurisdictions: British Columbia
Pharmagreen Biotech Inc. EXHIBIT 31.1 CERTIFICATION Peter Wojcik and Terry Kwan, certify that: 1. We have reviewed this quarterly report on Form 10-Q of Pharmagreen Biotech Inc. for the quarter ended June 30, 2023; 2. Based on our knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to m...